Is Starlink Set For The Largest IPO In History?

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Scott Peter Seidelmann net worth and biography

Scott Seidelmann Biography and Net Worth

EVP of Omnicell

Scott Seidelmann joined Omnicell in April 2018. Prior to joining Omnicell, Mr. Seidelmann was the founder and CEO of Candescent Health, a cloud-based radiology workflow and analytics provider. He was previously co-founder and CEO of Radisphere Inc., one of the largest radiology practices in the U.S., which leveraged technology and analytics to transform the radiology care delivery model to improve quality and lower costs. Earlier in his career, Mr. Seidelmann held positions with Merrill Lynch and Ericsson Venture Partners, a technology venture capital firm. He holds a Bachelor of Arts degree from Cornell University.

What is Scott Peter Seidelmann's net worth?: The estimated net worth of Scott Peter Seidelmann is at least $1.34 million as of December 27th, 2022. Mr. Seidelmann owns 29,788 shares of Omnicell stock worth more than $1,339,864 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Seidelmann may own. Learn More about Scott Peter Seidelmann's net worth.
How do I contact Scott Peter Seidelmann?: The corporate mailing address for Mr. Seidelmann and other Omnicell executives is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. Omnicell can also be reached via phone at (877) 415-9990 and via email at [email protected]. Learn More on Scott Peter Seidelmann's contact information.
Has Scott Peter Seidelmann been buying or selling shares of Omnicell?: Scott Peter Seidelmann has not been actively trading shares of Omnicell during the last ninety days. Most recently, Scott Peter Seidelmann sold 945 shares of the business's stock in a transaction on Tuesday, December 27th. The shares were sold at an average price of $48.28, for a transaction totalling $45,624.60. Following the completion of the sale, the executive vice president now directly owns 29,788 shares of the company's stock, valued at $1,438,164.64. Learn More on Scott Peter Seidelmann's trading history.
Who are Omnicell's active insiders?: Omnicell's insider roster includes Dan Johnston (EVP), James Judson (Director), Peter Kuipers (CFO), Randall Lipps (CEO), Christine Mellon (EVP), Scott Seidelmann (EVP), Robin Seim (Director), and Joseph Spears (CAO). Learn More on Omnicell's active insiders.
Are insiders buying or selling shares of Omnicell?: During the last year, insiders at the sold shares 1 times. They sold a total of 12,000 shares worth more than $567,600.00. The most recent insider tranaction occured on December, 10th when Director Mark W Parrish sold 12,000 shares worth more than $567,600.00. Insiders at Omnicell own 2.6% of the company. Learn More about insider trades at Omnicell.
Information on this page was last updated on 12/10/2024.

Scott Peter Seidelmann Insider Trading History at Omnicell

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/27/2022	Sell	945	$48.28	$45,624.60	29,788
12/16/2022	Sell	4,436	$47.79	$211,996.44	30,733
11/28/2022	Sell	1,793	$51.46	$92,267.78	38,996
6/16/2022	Sell	3,765	$110.15	$414,714.75	40,789
8/5/2021	Sell	41,878	$153.05	$6,409,427.90
6/16/2020	Sell	2,125	$67.70	$143,862.50	33,385
2/10/2020	Sell	2,833	$86.37	$244,686.21	23,641
12/16/2019	Sell	1,356	$80.59	$109,280.04	24,997
11/15/2019	Sell	2,833	$75.00	$212,475.00	26,333
10/11/2019	Sell	1,534	$75.26	$115,448.84	26,333
9/12/2019	Sell	1,300	$75.17	$97,721.00	26,333
6/17/2019	Sell	1,750	$81.55	$142,712.50	28,083
5/10/2019	Sell	8,500	$81.68	$694,280.00	28,929

Scott Peter Seidelmann Buying and Selling Activity at Omnicell

Omnicell Company Overview

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Today's Range

Now: $44.98

$43.49

$45.44

50 Day Range

MA: $45.55

$39.23

$53.05

2 Week Range

Now: $44.98

$25.12

$55.74

Volume

2,630,639 shs

Average Volume

546,148 shs

Market Capitalization

$2.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.77

Is Starlink Set For The Largest IPO In History?

From Paradigm Press | Ad

Click here now for the urgent details.